Article 2 IC50 2 Urease inhibition 2 binding affinity 2 biological activity 2 bovine serum albumin 2 carbon nuclear magnetic resonance 2 drug synthesis 2 enzyme inhibition 2 molecular docking 2 proton nuclear magnetic resonance 2 thin layer chromatography 2 unclassified drug 2 urease 2 1 [(4 chlorophenyl)sulfonyl]piperidin 4 carbohydrazide 1 1,2,4-Triazole 1 1,3,4-Oxadiazole 1 2 [(5 {1 [(4 methoxyphenyl)sulfonyl] 4 piperidinyl} 4 phenyl 4h 1,2,4 triazol 3 yl)sulfanyl] n (2 methylphenyl)acetamide 1 2 [(5 {1 [(4 methoxyphenyl)sulfonyl] 4 piperidinyl} 4 phenyl 4h 1,2,4 triazol 3 yl)sulfanyl] n (3 methylphenyl)acetamide 1 2 [(5 {1 [(4 methoxyphenyl)sulfonyl] 4 piperidinyl} 4 phenyl 4h 1,2,4 triazol 3 yl)sulfanyl] n (4 methylphenyl)acetamide 1 5 {1 [(4 chlorophenyl)sulfonyl]piperidin 4 yl} 2 (allylthio) 1,3,4 oxadiazole 1 5 {1 [(4 chlorophenyl)sulfonyl]piperidin 4 yl} 2 (benzylthio) 1,3,4 oxadiazole 1 5 {1 [(4 chlorophenyl)sulfonyl]piperidin 4 yl} 2 (ethylthio) 1,3,4 oxadiazole 1 5 {1 [(4 chlorophenyl)sulfonyl]piperidin 4 yl} 2 [(1 butyl)thio] 1,3,4 oxadiazole 1 5 {1 [(4 chlorophenyl)sulfonyl]piperidin 4 yl} 2 [(1 heptyl)thio] 1,3,4 oxadiazole 1 5 {1 [(4 chlorophenyl)sulfonyl]piperidin 4 yl} 2 [(1 octyl)thio] 1,3,4 oxadiazole 1 5 {1 [(4 chlorophenyl)sulfonyl]piperidin 4 yl} 2 [(1 pentyl)thio] 1,3,4 oxadiazole 1 5 {1 [(4 chlorophenyl)sulfonyl]piperidin 4 yl} 2 [(1 propyl)thio] 1,3,4 oxadiazole 1 5 {1 [(4 chlorophenyl)sulfonyl]piperidin 4 yl} 2 [(1,3 dioxalan 2 ylmethyl)thio] 1,3,4 oxadiazole 1 5 {1 [(4 chlorophenyl)sulfonyl]piperidin 4 yl} 2 [(2 bromobenzyl)thio] 1,3,4 oxadiazole 1